GDRX logo

GoodRx Holdings (GDRX) EBIT

annual EBIT:

$84.38M+$83.23M(+7199.48%)
December 31, 2024

Summary

  • As of today (June 2, 2025), GDRX annual earnings before interest & taxes is $84.38 million, with the most recent change of +$83.23 million (+7199.48%) on December 31, 2024.
  • During the last 3 years, GDRX annual EBIT has risen by +$70.92 million (+526.68%).
  • GDRX annual EBIT is now -36.34% below its all-time high of $132.55 million, reached on December 31, 2019.

Performance

GDRX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGDRXincome statement metrics

quarterly EBIT:

$27.31M+$4.54M(+19.96%)
March 31, 2025

Summary

  • As of today (June 2, 2025), GDRX quarterly earnings before interest & taxes is $27.31 million, with the most recent change of +$4.54 million (+19.96%) on March 31, 2025.
  • Over the past year, GDRX quarterly EBIT has increased by +$12.38 million (+82.86%).
  • GDRX quarterly EBIT is now -37.57% below its all-time high of $43.75 million, reached on March 31, 2020.

Performance

GDRX quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGDRXincome statement metrics

TTM EBIT:

$96.76M+$12.38M(+14.67%)
March 31, 2025

Summary

  • As of today (June 2, 2025), GDRX TTM earnings before interest & taxes is $96.76 million, with the most recent change of +$12.38 million (+14.67%) on March 31, 2025.
  • Over the past year, GDRX TTM EBIT has increased by +$97.39 million (+15289.64%).
  • GDRX TTM EBIT is now -36.22% below its all-time high of $151.72 million, reached on June 30, 2020.

Performance

GDRX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGDRXincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

GDRX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7199.5%+82.9%+10000.0%
3 y3 years+526.7%+37.9%+152.9%
5 y5 years-36.3%-37.6%-12.0%

GDRX EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+7199.5%at high+185.7%at high>+9999.0%
5 y5-year-36.3%+130.6%-37.6%+109.1%-36.2%+126.4%
alltimeall time-36.3%+130.6%-37.6%+109.1%-36.2%+126.4%

GDRX EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
$27.31M(+20.0%)
$96.76M(+14.7%)
Dec 2024
$84.38M(+7199.5%)
$22.77M(+11.2%)
$84.38M(+62.9%)
Sep 2024
-
$20.47M(-21.9%)
$51.80M(-9570.0%)
Jun 2024
-
$26.21M(+75.5%)
-$547.00K(-14.1%)
Mar 2024
-
$14.94M(-252.2%)
-$637.00K(-155.1%)
Dec 2023
$1.16M(-89.5%)
-$9.81M(-69.2%)
$1.16M(-93.6%)
Sep 2023
-
-$31.88M(-222.0%)
$18.15M(-51.3%)
Jun 2023
-
$26.12M(+56.1%)
$37.24M(+369.7%)
Mar 2023
-
$16.73M(+132.9%)
$7.93M(-28.0%)
Dec 2022
$11.01M
$7.18M(-156.1%)
$11.01M(-29.4%)
Sep 2022
-
-$12.79M(+301.0%)
$15.60M(-55.9%)
Jun 2022
-
-$3.19M(-116.1%)
$35.41M(-7.5%)
DateAnnualQuarterlyTTM
Mar 2022
-
$19.81M(+68.3%)
$38.26M(+184.1%)
Dec 2021
$13.46M(-104.9%)
$11.77M(+67.9%)
$13.46M(-104.5%)
Sep 2021
-
$7.01M(-2174.6%)
-$297.73M(-18.7%)
Jun 2021
-
-$338.00K(-93.2%)
-$366.40M(+13.0%)
Mar 2021
-
-$4.98M(-98.3%)
-$324.27M(+17.7%)
Dec 2020
-$275.54M(-307.9%)
-$299.42M(+385.6%)
-$275.54M(-630.5%)
Sep 2020
-
-$61.66M(-247.5%)
$51.94M(-65.8%)
Jun 2020
-
$41.79M(-4.5%)
$151.72M(+38.0%)
Mar 2020
-
$43.75M(+55.9%)
$109.92M(+66.1%)
Dec 2019
$132.55M(+77.8%)
$28.05M(-26.4%)
$66.17M(+73.6%)
Sep 2019
-
$38.12M
$38.12M
Dec 2018
$74.54M
-
-

FAQ

  • What is GoodRx Holdings annual earnings before interest & taxes?
  • What is the all time high annual EBIT for GoodRx Holdings?
  • What is GoodRx Holdings annual EBIT year-on-year change?
  • What is GoodRx Holdings quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for GoodRx Holdings?
  • What is GoodRx Holdings quarterly EBIT year-on-year change?
  • What is GoodRx Holdings TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for GoodRx Holdings?
  • What is GoodRx Holdings TTM EBIT year-on-year change?

What is GoodRx Holdings annual earnings before interest & taxes?

The current annual EBIT of GDRX is $84.38M

What is the all time high annual EBIT for GoodRx Holdings?

GoodRx Holdings all-time high annual earnings before interest & taxes is $132.55M

What is GoodRx Holdings annual EBIT year-on-year change?

Over the past year, GDRX annual earnings before interest & taxes has changed by +$83.23M (+7199.48%)

What is GoodRx Holdings quarterly earnings before interest & taxes?

The current quarterly EBIT of GDRX is $27.31M

What is the all time high quarterly EBIT for GoodRx Holdings?

GoodRx Holdings all-time high quarterly earnings before interest & taxes is $43.75M

What is GoodRx Holdings quarterly EBIT year-on-year change?

Over the past year, GDRX quarterly earnings before interest & taxes has changed by +$12.38M (+82.86%)

What is GoodRx Holdings TTM earnings before interest & taxes?

The current TTM EBIT of GDRX is $96.76M

What is the all time high TTM EBIT for GoodRx Holdings?

GoodRx Holdings all-time high TTM earnings before interest & taxes is $151.72M

What is GoodRx Holdings TTM EBIT year-on-year change?

Over the past year, GDRX TTM earnings before interest & taxes has changed by +$97.39M (+15289.64%)
On this page